The Form 4 filing, an SEC report of insider stock activity, was filed on November 12, 2026. It lists transaction dates from November 9 through November 11, 2026.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-11 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 25,008 |
| Price | $58.26 |
| Total Transaction Value | $1,456,978.00 |
| Insider | |
| Ticker Symbol | VCEL |
| Company | Vericel Corp |
| Insider Name | Mara Joseph Anthony Jr |
| Insider Title | Chief Financial Officer |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 16,186 |
| Position Size Change | 60.71% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales reported under SEC transaction code S. The transaction information also links the sales to a code M exercise or conversion. That is a step used to receive shares through an existing right.
What was the average price of the transaction?
The average sale price was $58.26 per share across the two reported transactions.
How did this transaction affect the insider's holdings?
Joseph Anthony Mara Jr. sold 25,008 shares and reported owning 16,186 shares afterward. The shares sold made up 60.71% of his reported shares before the sales.
What's the total transaction value?
The two sales had a total reported value of $1,456,978.00.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 reference. This kind of plan sets trading instructions in advance. The available details do not establish which sales the plan covered or when it began.
The exercise or conversion link is based on matching share counts within the same filing. That match does not confirm that the exact shares received were sold or that both steps happened on the same day. Details of the related exercise or conversion and the filing footnotes were not available, so those points remain unknown.
For research purposes only; not investment advice.